Previous studies report a correlation of [18F]FDG uptake with tumour aggressiveness, with increased SUVmax in primary breast tumours that are ER-negative, PR-negative, HER2-positive or Ki-67-positive [12–14]. The gene discussed is ERBB2; the disease is neoplasm.